Form 4: Director Eric Semler Boosts Strive Holdings Post-Merger
Insider Transaction Report
Strive, Inc. Director Eric Semler reports significant acquisition of Class A Common Stock and converted stock options following the merger with Semler Scientific, Inc. on January 16, 2026.
Summary
- Eric Semler, a Director of Strive, Inc. (ASST), reported changes in beneficial ownership of Class A Common Stock and derivative securities following the consummation of a merger with Semler Scientific, Inc. on January 16, 2026.
- In connection with the merger, each share of Semler common stock held by Mr. Semler was converted into the right to receive 21.05 shares of Strive Class A Common Stock.
- Mr. Semler directly acquired 13,395,083 shares of Class A Common Stock and indirectly acquired 1,637,079 shares through TCS Capital Advisors, LLC.
- Outstanding stock options in Semler common stock held by Mr. Semler were converted into rights to purchase Strive Class A Common Stock (Converted Options) on substantially the same terms.
- The number of shares subject to each Converted Option was multiplied by 21.05 (rounded down), and the per share exercise price was divided by 21.05 (rounded up).
- All Converted Options are fully vested and exercisable as of the closing of the merger.
Sentiment
Score: 7
Explanation: The filing reports a significant increase in a director's beneficial ownership of Strive, Inc. Class A Common Stock and converted stock options following the successful consummation of a merger, indicating strong alignment of interests and the completion of a strategic event.
Positives
- A director, Eric Semler, significantly increased his beneficial ownership in Strive, Inc. Class A Common Stock, indicating strong alignment with shareholder interests.
- The successful consummation of the merger with Semler Scientific, Inc. is a positive strategic development for Strive, Inc.
Future Outlook
The filing does not contain forward-looking statements or guidance, as it is a report of a completed insider transaction.
Industry Context
This filing reflects the post-merger integration phase for Strive, Inc., where the equity holdings of former Semler Scientific, Inc. stakeholders, including directors, are being converted into Strive, Inc. securities. Such transactions are typical following the consummation of a corporate merger and indicate the operational and legal completion of the acquisition.
Related Party Transactions
- Eric Semler's indirect beneficial ownership of 1,637,079 shares of Class A Common Stock is held by TCS Capital Advisors, LLC. Mr. Semler is the managing member of TCS Capital Management, LLC, the investment advisor of TCS Advisors, and may be deemed to beneficially own these securities, though he disclaims beneficial ownership except to the extent of his pecuniary interest.
Stakeholder Impact
- Shareholders of Semler Scientific, Inc. have had their holdings converted into Strive, Inc. Class A Common Stock, impacting their investment vehicle.
- Strive, Inc. shareholders benefit from increased insider ownership, which can signal confidence in the company's future post-merger.
Next Steps
- Continued integration of Semler Scientific, Inc. operations and assets into Strive, Inc.
Key Dates
| Date | Description |
|---|---|
| 09/22/2025 | Date of the Agreement and Plan of Merger between Registrant and Semler Scientific, Inc. |
| 01/16/2026 | Date of earliest transaction; consummation of the merger with Semler Scientific, Inc. and conversion of Semler common stock and options into Strive Class A Common Stock and Converted Options. |
| 05/24/2026 | Expiration date for a tranche of Converted Stock Options with an exercise price of $1.11. |
| 01/29/2027 | Expiration date for a tranche of Converted Stock Options with an exercise price of $2.80. |
| 05/28/2027 | Expiration date for a tranche of Converted Stock Options with an exercise price of $1.72. |
| 01/06/2035 | Expiration date for a tranche of Converted Stock Options with an exercise price of $2.80. |
| 05/02/2035 | Expiration date for a tranche of Converted Stock Options with an exercise price of $1.72. |
| 01/02/2036 | Expiration date for a tranche of Converted Stock Options with an exercise price of $0.85. |
Keywords
Strive Inc, ASST, Eric Semler, Form 4, insider transaction, beneficial ownership, merger, Semler Scientific, stock options, Class A Common Stock, director holdings
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.